Concert Pharmaceuticals, Inc.
CNCEDelisted Mar 6, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001367920
Concert Pharmaceuticals, Inc. was delisted on Mar 6, 2023; its insiders filed their last Form 4 on Mar 6, 2023; 85 institutions reported holding it in 13F filings for Q4 2022, worth $207.2M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Concert Pharmaceuticals, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 52 | 53 | +1 |
| Shares | 18.1M | 17.2M | −927.6K (−5.1%) |
| Value | $57.1M | $58.0M | +$881.8K (+1.5%) |
New holders (9)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Parkman Healthcare Partners LLC | 377,399 | $1.27M | 0.37% |
| Charles Schwab Investment Management Inc | 23,681 | $80.0K | 0.00% |
| Jane Street Group, LLC | 16,627 | $56.0K | 0.00% |
| Susquehanna International Group, LLP | 15,476 | $52.0K | 0.00% |
| HRT Financial LP | 14,470 | $48.0K | 0.00% |
| Virtu Financial LLC | 13,927 | $47.0K | 0.00% |
| Roanoke Asset Management Corp | 10,000 | $34.0K | 0.01% |
| Simplex Trading, LLC | 8,468 | $28.0K | 0.00% |
| De Burlo Group Inc | 200 | $674 | 0.00% |
Sold out (8)
Institutions that held Concert Pharmaceuticals, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| IndexIQ Advisors LLC | 84,631 | $267.0K |
| Marshall Wace, LLP | 45,383 | $143.0K |
| Truist Financial Corp | 20,000 | $63.0K |
| Algert Global LLC | 19,300 | $61.0K |
| XTX Topco Ltd | 14,305 | $45.0K |
| Cubist Systematic Strategies, LLC | 12,254 | $39.0K |
| Two Sigma Securities, LLC | 10,921 | $34.0K |
| Dynamic Technology Lab Private Ltd | 10,536 | $33.0K |